Global buyout giant KKR has closed KKR Health Care Strategic Growth Fund II on $4bn, just shy of tripling the size of its $1.45bn predecessor fund I which was closed in 2017.
KKR has made $18bn of investments in the health care industry since 2004, including buying into Argenta, Nordic Bioscience, Sapphiros, Geode Health, and Cordis last year.
The firm has also pulled in $16.8bn for its mammoth new North America Fund XIII fundraise in November and closed its third US-focused opportunistic real estate fund on $4.3bn in October.
Read more/Source: Alt Assets
